Cargando…
Muscarinic Receptors and Their Antagonists in COPD: Anti-Inflammatory and Antiremodeling Effects
Muscarinic receptors are expressed by most cell types and mediate cellular signaling of their natural ligand acetylcholine. Thereby, they control numerous central and peripheral physiological organ responses to neuronal activity. In the human lung, muscarinic receptors are predominantly expressed by...
Autores principales: | Karakiulakis, George, Roth, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512336/ https://www.ncbi.nlm.nih.gov/pubmed/23226927 http://dx.doi.org/10.1155/2012/409580 |
Ejemplares similares
-
Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001) -
Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy
por: Kovács, Zsuzsanna Z. A., et al.
Publicado: (2021) -
Muscarinic receptor signaling in the pathophysiology of asthma and COPD
por: Gosens, Reinoud, et al.
Publicado: (2006) -
Investigating the
Unbinding of Muscarinic Antagonists
from the Muscarinic 3 Receptor
por: Buigues, Pedro J., et al.
Publicado: (2023) -
Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD
por: D’Urzo, Anthony D, et al.
Publicado: (2018)